Role of the Epstein-Barr Virus Rta Protein in Activation of Distinct Classes of Viral Lytic Cycle Genes
暂无分享,去创建一个
[1] T. Ragoczy,et al. Amino Acid Substitutions Reveal Distinct Functions of Serine 186 of the ZEBRA Protein in Activation of Early Lytic Cycle Genes and Synergy with the Epstein-Barr Virus R Transactivator , 1999, Journal of Virology.
[2] S. Kenney,et al. Rescue of the Epstein-Barr virus BZLF1 mutant, Z(S186A), early gene activation defect by the BRLF1 gene product. , 1998, Virology.
[3] T. Ragoczy,et al. The Epstein-Barr Virus Rta Protein Activates Lytic Cycle Genes and Can Disrupt Latency in B Lymphocytes , 1998, Journal of Virology.
[4] M. Carey,et al. Compensatory Energetic Relationships between Upstream Activators and the RNA Polymerase II General Transcription Machinery* , 1998, The Journal of Biological Chemistry.
[5] G. Miller,et al. Late gene expression from the Epstein-Barr virus BcLF1 and BFRF3 promoters does not require DNA replication in cis , 1997, Journal of virology.
[6] L. Gradoville,et al. Alteration of a single serine in the basic domain of the Epstein-Barr virus ZEBRA protein separates its functions of transcriptional activation and disruption of latency , 1997, Journal of virology.
[7] S. Kenney,et al. The cellular YY1 transcription factor binds a cis-acting, negatively regulating element in the Epstein-Barr virus BRLF1 promoter , 1997, Journal of virology.
[8] G. Suske,et al. Binding of the ubiquitous cellular transcription factors Sp1 and Sp3 to the ZI domains in the Epstein-Barr virus lytic switch BZLF1 gene promoter. , 1997, Virology.
[9] E. Flemington,et al. G0/G1 Growth Arrest Mediated by a Region Encompassing the Basic Leucine Zipper (bZIP) Domain of the Epstein-Barr Virus Transactivator Zta* , 1996, The Journal of Biological Chemistry.
[10] R. Sun,et al. Two 21-kilodalton components of the Epstein-Barr virus capsid antigen complex and their relationship to ZEBRA-associated protein p21 (ZAP21) , 1996, Journal of virology.
[11] S. Kenney,et al. Epstein-Barr viral latency is disrupted by the immediate-early BRLF1 protein through a cell-specific mechanism. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[12] J. Strominger,et al. Characterization of the ZI domains in the Epstein-Barr virus BZLF1 gene promoter: role in phorbol ester induction , 1996, Journal of virology.
[13] E. Flemington,et al. The Epstein‐Barr virus bZIP transcription factor Zta causes G0/G1 cell cycle arrest through induction of cyclin‐dependent kinase inhibitors. , 1996, The EMBO journal.
[14] L. Corbo,et al. Epstein-Barr virus (EBV) EB1/Zta protein provided in trans and competent for the activation of productive cycle genes does not activate the BZLF1 gene in the EBV genome. , 1996, The Journal of general virology.
[15] J. Countryman,et al. Comparing transcriptional activation and autostimulation by ZEBRA and ZEBRA/c-Fos chimeras , 1996, Journal of virology.
[16] T. Ooka,et al. The lytic cycle of Epstein-Barr virus in the nonproducer Raji line can be rescued by the expression of a 135-kilodalton protein encoded by the BALF2 open reading frame , 1995, Journal of virology.
[17] M. Marschall,et al. Different activation of Epstein-Barr virus immediate-early and early genes in Burkitt lymphoma cells and lymphoblastoid cell lines , 1994, Journal of virology.
[18] W. Hammerschmidt,et al. A transcription factor with homology to the AP‐1 family links RNA transcription and DNA replication in the lytic cycle of Epstein‐Barr virus. , 1993, The EMBO journal.
[19] W. Hammerschmidt,et al. cis-acting elements in the lytic origin of DNA replication of Epstein-Barr virus , 1993, Journal of virology.
[20] E. van Heerde,et al. Gene mapping and expression of two immunodominant Epstein-Barr virus capsid proteins , 1993, Journal of virology.
[21] M. Carey,et al. Transcriptional synergy by the Epstein-Barr virus transactivator ZEBRA , 1992, Journal of virology.
[22] I. Mellinghoff,et al. Early events in Epstein-Barr virus genome expression after activation: regulation by second messengers of B cell activation. , 1991, Virology.
[23] D. Dorsky,et al. Cooperation of EBV DNA polymerase and EA-D(BMRF1) in vitro and colocalization in nuclei of infected cells. , 1991, Virology.
[24] P. Farrell,et al. Pathways of activation of the Epstein-Barr virus productive cycle , 1991, Journal of virology.
[25] J. Nicolas,et al. Transcriptional interference between the EBV transcription factors EB1 and R: both DNA-binding and activation domains of EB1 are required. , 1991, Nucleic acids research.
[26] H. Sato,et al. Concatameric replication of Epstein-Barr virus: structure of the termini in virus-producer and newly transformed cell lines , 1990, Journal of virology.
[27] E. Flemington,et al. Identification of phorbol ester response elements in the promoter of Epstein-Barr virus putative lytic switch gene BZLF1 , 1990, Journal of virology.
[28] J. Hardwick,et al. An enhancer within the divergent promoter of Epstein-Barr virus responds synergistically to the R and Z transactivators , 1990, Journal of virology.
[29] M. Buisson,et al. The Epstein-Barr virus (EBV) early protein EB2 is a posttranscriptional activator expressed under the control of EBV transcription factors EB1 and R , 1989, Journal of virology.
[30] D. Markovitz,et al. The Epstein-Barr virus immediate-early gene product, BMLF1, acts in trans by a posttranscriptional mechanism which is reporter gene dependent , 1989, Journal of virology.
[31] C. Rooney,et al. The spliced BZLF1 gene of Epstein-Barr virus (EBV) transactivates an early EBV promoter and induces the virus productive cycle , 1989, Journal of virology.
[32] J. Giot,et al. Epstein‐Barr virus bicistronic mRNAs generated by facultative splicing code for two transcriptional trans‐activators. , 1989, The EMBO journal.
[33] S. Altman,et al. Identification and characterization of an RNA molecule that copurifies with RNase P activity from HeLa cells. , 1989, Genes & development.
[34] G. Miller,et al. Polymorphisms of the region of the Epstein-Barr virus genome which disrupts latency. , 1988, Virology.
[35] P. Lieberman,et al. A new Epstein-Barr virus transactivator, R, induces expression of a cytoplasmic early antigen , 1988, Journal of virology.
[36] B. Barrell,et al. Sequence analysis of Raji Epstein-Barr virus DNA. , 1988, Virology.
[37] E. Huang,et al. Transfer and Expression of Plasmids Containing Human Cytomegalovirus Immediate‐Early Gene 1 Promoter‐Enhancer Sequences in Eukaryotic and Prokaryotic Cells , 1988, Biotechnology and applied biochemistry.
[38] M. Perricaudet,et al. Epstein-Barr virus gene expression in P3HR1-superinfected Raji cells , 1987, Journal of virology.
[39] E. Kieff,et al. Identification of an Epstein-Barr virus early gene encoding a second component of the restricted early antigen complex. , 1987, Virology.
[40] R. S. Tan,et al. Association of Epstein-Barr virus early antigen diffuse component and virus-specified DNA polymerase activity , 1987, Journal of virology.
[41] L. Heston,et al. Transfection of a rearranged viral DNA fragment, WZhet, stably converts latent Epstein-Barr viral infection to productive infection in lymphoid cells. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[42] B. Barrell,et al. Coding content and expression of the EBV B95-8 genome in the region from base 62,248 to base 82,920. , 1986, Virology.
[43] M. Ptashne. A Genetic Switch: Gene Control and Phage Lambda , 1986 .
[44] K. Takada,et al. trans activation of the latent Epstein-Barr virus (EBV) genome after transfection of the EBV DNA fragment , 1986, Journal of virology.
[45] J. Countryman,et al. Activation of expression of latent Epstein-Barr herpesvirus after gene transfer with a small cloned subfragment of heterogeneous viral DNA. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[46] P. L. Deininger,et al. DNA sequence and expression of the B95-8 Epstein—Barr virus genome , 1984, Nature.
[47] B. Barrell,et al. Homology between two EBV early genes and HSV ribonucleotide reductase and 38K genes. , 1984, Nucleic acids research.
[48] B. Barrell,et al. Transcription and DNA sequence of the BamHI L fragment of B95‐8 Epstein‐Barr virus. , 1984, The EMBO journal.
[49] A. Polack,et al. Two deletions in the Epstein-Barr virus genome of the Burkitt lymphoma nonproducer line Raji. , 1984, Virology.
[50] E. Kieff,et al. Identification of polypeptide components of the Epstein-Barr virus early antigen complex with monoclonal antibodies , 1983, Journal of virology.
[51] L. Heston,et al. Identification of a rare Epstein-Barr virus variant that enhances early antigen expression in Raji cells. , 1983, Proceedings of the National Academy of Sciences of the United States of America.
[52] H. Hausen,et al. Persisting oncogenic herpesvirus induced by the tumour promoter TPA , 1978, Nature.
[53] R. Pulvertaft,et al. CYTOLOGY OF BURKITT'S TUMOUR (AFRICAN LYMPHOMA). , 1964, Lancet.
[54] T. Chatila,et al. Cyclosporin A‐sensitive induction of the Epstein‐Barr virus lytic switch is mediated via a novel pathway involving a MEF2 family member , 1997, The EMBO journal.
[55] M. Ptashne. A genetic switch : phage λ and higher organisms , 1992 .
[56] J. Kolman,et al. Viral proteins associated with the Epstein-Barr virus transactivator, ZEBRA. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[57] G. Miller,et al. Release of infectious Epstein-Barr virus by transformed marmoset leukocytes. , 1973, Proceedings of the National Academy of Sciences of the United States of America.